Michael Rabson Insider Profile

4 Followers
Michael Rabson, SVP Business Dev/Legal & GC at Cytokinetics, holds 20.04K shares in Cytokinetics (Ticker: CYTK). Most recently, Michael Rabson Bought $15,000 shares of Cytokinetics on Dec 21, 2009 for an estimated value of 27.75K.
Michael Rabson

Michael Rabson
Cytokinetics (CYTK)
SVP Business Dev/Legal & GC

Not Ranked
Michael Rabson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$708K
100.00%
A breakdown of Michael Rabson's holdings

Insider Roles

Cytokinetics
(CYTK)
SVP Business Dev/Legal & GC
Roles that Michael Rabson holds in companies

Most Profitable Insider Trade

Stock:
Cytokinetics
(CYTK)
Rating:Informative Buy
Date:Dec 21, 2009 - Dec 21, 2010
Return:-17.70%
The most profitable trade made by Michael Rabson

Michael Rabson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cytokinetics
Dec 21, 2009
SVP Business Dev/Legal & GC
Informative Buy
$27.75K
$708.12K
Success Rate for CYTK
0 out of 1 profitable transactions on CYTK
0%
Average Return for CYTK
Average return per transaction on CYTK
-17.70%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 21, 2009
Informative Buy
$27.75K
-
$1.85
-17.70%
List of latest transactions for each holding click on a transaction to see Michael Rabson's performance on stock

Michael Rabson insider profile FAQ

What is the percentage of profitable transactions made by Michael Rabson?
The percentage of profitable transactions made by Michael Rabson is ―.
    What is the average return per transaction made by Michael Rabson?
    The average return per transaction made by Michael Rabson is ―.
      What stocks does Michael Rabson hold?
      Michael Rabson holds: CYTK stocks.
        What was Michael Rabson’s latest transaction?
        Michael Rabson latest transaction was an Informative Buy of $27.75K.
          What was Michael Rabson's most profitable transaction?
          Michael Rabson’s most profitable transaction was an Informative Buy of CYTK stock on December 21, 2009. The return on the trade was -17.70%.
            What is Michael Rabson's role in Cytokinetics?
            Michael Rabson's role in Cytokinetics is SVP Business Dev/Legal & GC.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.